X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adolescent (2) 2
adult (2) 2
aged (2) 2
female (2) 2
hodgkin disease - drug therapy (2) 2
humans (2) 2
male (2) 2
middle aged (2) 2
2nd malignancy (1) 1
6 cycles (1) 1
alkylating-agents (1) 1
alternating chemotherapy (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
bleomycin - administration & dosage (1) 1
bone marrow (1) 1
cancer (1) 1
care and treatment (1) 1
chemotherapy (1) 1
combined modality therapy (1) 1
cooperative group (1) 1
detudes-des-lymphomes (1) 1
disease (1) 1
disease survivors (1) 1
doxorubicin - administration & dosage (1) 1
evaluation (1) 1
fatigue (1) 1
follow-up studies (1) 1
general-population (1) 1
hematology, oncology and palliative medicine (1) 1
hodgkin disease - mortality (1) 1
hodgkin disease - pathology (1) 1
hodgkin disease - psychology (1) 1
hodgkin disease - radiotherapy (1) 1
hodgkin's disease (1) 1
index medicus (1) 1
instrument (1) 1
ladulte h89 trial (1) 1
life sciences (1) 1
long-term survivors (1) 1
lymphomas (1) 1
mechlorethamine - administration & dosage (1) 1
medicine, general & internal (1) 1
metabolic disorders (1) 1
neoplasm staging (1) 1
neoplasms, second primary - epidemiology (1) 1
oncology (1) 1
prednisone - administration & dosage (1) 1
procarbazine - administration & dosage (1) 1
qlq-c30 (1) 1
quality of life (1) 1
radiotherapy (1) 1
remission induction (1) 1
risk (1) 1
salvage therapy (1) 1
survival analysis (1) 1
vinblastine - administration & dosage (1) 1
vincristine - administration & dosage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 12, pp. 1160 - 1170
Summary Background Little is known about the longitudinal course of health-related quality of life (HRQoL) in patients with Hodgkin's lymphoma during their... 
Hematology, Oncology and Palliative Medicine | INSTRUMENT | LONG-TERM SURVIVORS | GENERAL-POPULATION | ONCOLOGY | FATIGUE | QLQ-C30 | DISEASE SURVIVORS | CANCER | Hodgkin Disease - psychology | Follow-Up Studies | Humans | Middle Aged | Adolescent | Hodgkin Disease - drug therapy | Quality of Life | Adult | Female | Male | Aged
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2003, Volume 348, Issue 24, pp. 2396 - 2406
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.